Brief: Relief Therapeutics Says APR Applied Pharma Research Starts Clinical Trial With Nasal Spray APR-AOS2020

MindMaze Therapeutics Holding SA

17/05/2021 06:04

May 17 (Reuters) - RELIEF THERAPEUTICS HOLDING SA  RLFB.S :
    * APR APPLIED PHARMA RESEARCH S.A. ("APR") STARTS CLINICAL
TRIAL
WITH NASAL SPRAY APR-AOS2020
    * TRIAL TO EVALUATE EFFICACY AND SAFETY IN REDUCING VIRAL
LOAD IN
UPPER RESPIRATORY AIRWAYS IN PATIENTS RECENTLY RECENTLY INFECTED
WITH COVID-19

Source text for Eikon:  ID:nEQ2WwXLYa 
Further company coverage:  RLFB.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))